Bajaj Healthcare rose 3.15% to Rs 923.90 after the company said that its board will meet on Friday, 13 August 2021, to consider and approve sub-division/ stock-split of equity shares of the company.
The announcement was made after market hours yesterday.
Bajaj Healthcare is a leading manufacturer of APIs, intermediates and formulations. It specializes in manufacturing of of amino acids, intermediates, API, formulations & nutraceuticals.
The company's net profit surged 69.43% to Rs 21.28 crore on a 11.54% increase in net sales to Rs 132.18 crore in Q4 FY21 over Q4 FY20.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
